BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26891163)

  • 1. A Mathematical Model Coupling Tumor Growth and Angiogenesis.
    Xu J; Vilanova G; Gomez H
    PLoS One; 2016; 11(2):e0149422. PubMed ID: 26891163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
    Oon CE; Harris AL
    Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4.
    Deng J; Liu X; Rong L; Ni C; Li X; Yang W; Lu Y; Yan X; Qin C; Zhang L; Qin Z
    J Pathol; 2014 Jun; 233(2):170-82. PubMed ID: 24615277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation.
    Tang L; van de Ven AL; Guo D; Andasari V; Cristini V; Li KC; Zhou X
    PLoS One; 2014; 9(1):e83962. PubMed ID: 24404145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells.
    Zhao XC; Dou GR; Wang L; Liang L; Tian DM; Cao XL; Qin HY; Wang CM; Zhang P; Han H
    Neoplasia; 2013 Jul; 15(7):815-25. PubMed ID: 23814493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dll4-Notch signaling in regulation of tumor angiogenesis.
    Liu Z; Fan F; Wang A; Zheng S; Lu Y
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):525-36. PubMed ID: 24114288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
    Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
    PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis.
    Klose R; Adam MG; Weis EM; Moll I; Wüstehube-Lausch J; Tetzlaff F; Oka C; Ehrmann M; Fischer A
    Oncogene; 2018 Aug; 37(31):4260-4272. PubMed ID: 29713059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-like 4/Notch signaling promotes Apc
    Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
    BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.
    Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL
    Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A coupled finite element model of tumor growth and vascularization.
    Lloyd BA; Szczerba D; Székely G
    Med Image Comput Comput Assist Interv; 2007; 10(Pt 2):874-81. PubMed ID: 18044651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
    Lin YC; Liu CY; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy.
    Jafari Nivlouei S; Soltani M; Carvalho J; Travasso R; Salimpour MR; Shirani E
    PLoS Comput Biol; 2021 Jun; 17(6):e1009081. PubMed ID: 34161319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
    Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
    Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pivotal role of angiogenesis in a multi-scale modeling of tumor growth exhibiting the avascular and vascular phases.
    Salavati H; Soltani M; Amanpour S
    Microvasc Res; 2018 Sep; 119():105-116. PubMed ID: 29742454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis.
    Thurston G; Kitajewski J
    Br J Cancer; 2008 Oct; 99(8):1204-9. PubMed ID: 18827808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
    Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
    PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.
    Dos Santos SN; Sheldon H; Pereira JX; Paluch C; Bridges EM; El-Cheikh MC; Harris AL; Bernardes ES
    Oncotarget; 2017 Jul; 8(30):49484-49501. PubMed ID: 28533486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
    Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
    Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.